These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37905647)

  • 1. Expression of miRNA-451 and miRNA-885 in Meningiomas.
    Baran O; Karaoglu AC; Kara E; Budun O; Katar S; Yilmaz SG; Akdeniz FT; Ambarcioglu MA; Demirel N; Turk O; Ozdemir NG; Yaltirik CK; Isbir T
    In Vivo; 2023; 37(6):2473-2479. PubMed ID: 37905647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA expression signature predicts meningioma recurrence.
    Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
    Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma.
    Katar S; Baran O; Evran S; Cevik S; Akkaya E; Baran G; Antar V; Hanimoglu H; Kaynar MY
    Clin Neurol Neurosurg; 2017 May; 156():66-70. PubMed ID: 28349893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological and diagnostic roles of MicroRNAs in meningiomas.
    Wang L; Chen S; Liu Y; Zhang H; Ren N; Ma R; He Z
    Rev Neurosci; 2020 Oct; 31(7):771-778. PubMed ID: 32697762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
    Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
    Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
    Foiani G; Guelfi G; Mandara MT
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Expression of MIR17HG Protein as a Potential Therapeutic Target in Meningioma.
    Evran S; Baran O; Kayhan A; Katar S; Akkaya E; Cevik S; Kaya M; Sonmez D; Serin H; Kaynar MY
    World Neurosurg; 2020 May; 137():e554-e563. PubMed ID: 32068173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
    Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
    World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
    Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
    Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
    Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
    BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
    Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J
    Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.
    Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y
    Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
    Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z
    J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
    Bie L; Zhao G; Ju Y; Zhang B
    Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
    Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
    Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.